Logo of scirepAboutEditorial BoardFor AuthorsScientific Reports
PMC full text:
Published online 2024 Feb 20. doi: 10.1038/s41598-024-54431-z

Table 2

Renal and functional outcomes after augmentation cystoplasty.

VariablePreoperativelyPostoperativelyp value
Hydronephrosis< 0.001
  No hydronephrosis3 (13.6%)19 (86.4%)
  UTD P14 (18.2%)1 (4.5%)
  UTD P26 (27.3%)0 (0.0%)
  UTD P39 (40.9%)2 (9.1%)
Number of renal units with VUR (n = 44)< 0.001
  No VUR19 (43.2%)35 (79.5%)
  Grade I4 (9.1%)4 (9.1%)
  Grade II0 (0.0%)2 (4.5%)
  Grade III4 (9.1%)1 (2.3%)
  Grade IV9 (20.5%)2 (4.5%)
  Grade V8 (18.2%)0 (0.0%)
Renal function outcome
  Creatinine (mg/dL)0.8 ± 0.60.9 ± 0.80.230
  eGFR (mL/min/1.73 m2)80.6 ± 33.998.3 ± 39.50.012
  CKD stage0.115
    CKD stage 18 (36.4%)13 (59.1%)
    CKD stage 28 (36.4%)6 (27.3%)
    CKD stage 35 (22.7%)2 (9.1%)
    CKD stage 41 (4.5%)0 (0.0%)
    CKD stage 50 (0.0%)1 (4.5%)
Urinary continence5 (22.7%)18 (81.8%)< 0.001

CKD chronic kidney disease, eGFR estimated glomerular filtration rate, UTD urinary tract dilation, VUR vesicoureteral reflux.